From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities

Individuals given the same medicinal polysaccharide can differ in substrate utilization, metabolite production and host response. Accessible glycan structure, effective colonic exposure and the recipient’s carbohydrate-active enzyme (CAZyme) systems help explain these differences. This review examines compatibility from microbial substrate acquisition to host effects and separates substrate utilization, microbial products and host outcomes. Medicinal-glycan studies identify selective utilization, substrate-induced polysaccharide utilization loci and catalytic reactions, with genetic evidence for selected systems. Utilization specificity and prevalence of compatible functions jointly influence community responses, while enzyme induction, competition, metabolic exchange, absorption, direct glycan recognition and preparation composition shape conversion and host exposure. We propose selecting candidate predictors from these response processes and testing them against prespecified endpoints. Human dietary-fiber studies provide complementary evidence for taxonomic prediction, functional biomarkers and fermentation-guided choice. The available evidence supports a proof-of-concept rationale, not a clinically validated rule for selecting medicinal polysaccharides, and the reviewed studies do not establish improved host outcomes from a matching rule. The key test is whether explicit glycan–utilization matching improves prediction beyond taxonomy and the separate effects of structure and function. Paired comparisons under common validation conditions can isolate that contribution, while baseline fermentation can add information when screening and validation endpoints are measured independently. Predicting response to one preparation and choosing the best preparation require different evidence. The practical value of matching depends on improving host outcomes over a common preparation or usual selection practice.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-17
DOI
https://doi.org/10.3390/ph19111827
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities

Yongjun Kan, Wensheng Pang, Juan Hu, Chang Jiang et al.
3 links
Pharmaceuticals
Gut microbiota and health
article

From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities

Yongjun Kan, Wensheng Pang, Juan Hu, Chang Jiang, Yang Liu, Li Zhao, Wenxiong Lin
article en

Abstract

Individuals given the same medicinal polysaccharide can differ in substrate utilization, metabolite production and host response. Accessible glycan structure, effective colonic exposure and the recipient’s carbohydrate-active enzyme (CAZyme) systems help explain these differences. This review examines compatibility from microbial substrate acquisition to host effects and separates substrate utilization, microbial products and host outcomes. Medicinal-glycan studies identify selective utilization, substrate-induced polysaccharide utilization loci and catalytic reactions, with genetic evidence for selected systems. Utilization specificity and prevalence of compatible functions jointly influence community responses, while enzyme induction, competition, metabolic exchange, absorption, direct glycan recognition and preparation composition shape conversion and host exposure. We propose selecting candidate predictors from these response processes and testing them against prespecified endpoints. Human dietary-fiber studies provide complementary evidence for taxonomic prediction, functional biomarkers and fermentation-guided choice. The available evidence supports a proof-of-concept rationale, not a clinically validated rule for selecting medicinal polysaccharides, and the reviewed studies do not establish improved host outcomes from a matching rule. The key test is whether explicit glycan–utilization matching improves prediction beyond taxonomy and the separate effects of structure and function. Paired comparisons under common validation conditions can isolate that contribution, while baseline fermentation can add information when screening and validation endpoints are measured independently. Predicting response to one preparation and choosing the best preparation require different evidence. The practical value of matching depends on improving host outcomes over a common preparation or usual selection practice.

PharmaceuticalsVol. 19(11)
Fujian University of Traditional Chinese Medicine (CN), Fujian Academy of Medical Sciences (CN), Fujian Academy of Chinese Medicine Sciences (CN), Fujian Agriculture and Forestry University (CN)
National Natural Science Foundation of China
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon